Investing

Anyone who agrees the S&P 500 could cross that landmark can mimic the private-market trades by trading call options on the State Street SPDR S&P 500 ETF.

Five ARK ETFs purchased a combined 141,108 AMD shares on Wednesday, following the chip maker’s biggest drop in more than eight years.

Americans weighed down by student loans are putting off key life events such as the purchase of a home.

The growth of AI agents creates increased demand for Okta’s services. The stock is a buy.

Morningstar and PitchBook have developed a series of indexes to track the performance of the growing number of semiliquid funds investing in private markets.

Banks’ dividends are growing at a good clip and, more important, their fundamentals look solid.

A steep selloff in software should be a wake-up call to diversify and take other measures to keep your portfolio aloft.

The equipment manufacturer’s stock has outperformed the S&P 500 since we recommended buying it a year ago. Let it ride.

Earnings beat expectations but the stock still dropped. The thesis remains intact. Stay invested.

A J.P. Morgan Private Bank survey of global single-family offices find more than half aren’t exposed to private companies leading the AI boom.

More alternative investments are available in exchange-traded funds, making it easier for retail investors to own them.

Artificial Intelligence may find deductions or credits you missed, catch an error on your tax return, or spot a red flag that could lead to an audit.

Activists also report to the SEC on Rogers, Apogee Therapeutics, and Cogent Biosciences.

The markets in the hands of Big Tech once again. That’s worrisome, given the concerns around the AI bubble and circular spending that has consumed investors in recent months.

Some 68% of gold’s price movement over the past year is explained by U.S. policy shifts.

President Trump has threatened to restrict defense companies’ dividends and stock buybacks. How worried should investors be?

Innodata stock has gained 73% since our recommendation. This deal only helps.

With its shares down 17% this week, much of its problems may now be reflected in the stock price.

The stock has moved little despite impressive financial results. Its expansion into private credit is one avenue to growth.

Retirees are likely to see costs increase at a faster clip than the 3.5% official inflation rate for healthcare. Taking these steps can help.

Merck, which reports Feb. 3, looks especially compelling.

Investors are expected to allocate more to private markets in search of returns and diversification, according to a survey by Hamilton Lane.

Financial markets have a new attitude, exemplified by innovations like prediction markets and zero-dated options. Many people view the markets as a casino.

The head of financial planning at Morgan Stanley discusses why the traditional retirement model is becoming obsolete and why advisors should embrace scenario planning.

These stocks are benefiting from a global armaments push.